Redcare Pharmacy NV provided earnings guidance for the full year 2023. For the year, the company confirmed the guidance of net sales EUR 1.7 billion to EUR 1.8 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
100.7 EUR | +2.76% | -17.04% | -24.35% |
09:33am | REDCARE PHARMACY : Buy rating from Hauck & Aufhauser | ZD |
May. 21 | REDCARE PHARMACY : Receives a Sell rating from UBS | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.35% | 2.16B | |
-36.12% | 14.39B | |
-27.49% | 11.63B | |
-25.47% | 6.41B | |
-7.51% | 6.23B | |
+15.31% | 6.45B | |
+74.92% | 5.1B | |
-2.34% | 4.64B | |
-8.67% | 3.92B | |
-10.64% | 3.5B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Provides Earnings Guidance for the Full Year 2023